MedTrace Logo

Prophylactic Amiodarone for Shockable Cardiac Arrest

NCT04845607 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 302

Last updated 2021-06-21

No results posted yet for this study

Summary

The aim of this study is to determine whether the prophylactic amiodarone can prevent re-arrest with ventricular shockable rhythm in patients who treated with targeted temperature management after return of spontaneous circulation from cardiac arrest which had been shockable rhythm during CPR.

Conditions

  • Cardiac Arrest
  • Ventricular Arrythmia

Interventions

DRUG

Amiodarone Injection

Amiodarone continuous infusion during 24 hours from return of spontaneous circulation.

Sponsors & Collaborators

  • Won Young Kim

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04845607 on ClinicalTrials.gov